Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Figure out How to Store Your Gold Ventures: A Thorough Aide safely19.10.2023 - 2Figure out How to Reveal Stowed away Open Record Rewards19.10.2023
- 3Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.24.12.2025
- 4CDC clarifies stance on vaccines and autism, stating no evidence supports the link20.11.2025
- 5UK can legally stop shadow fleet tankers, ministers believe11.01.2026
- Unpaid caregiving work can feel small and personal, but that doesn’t take away its ethical value
- Famous SUVs With Low Energy Utilization In 2024
- Blue Origin launches huge rocket carrying twin NASA spacecraft to Mars
- Bondi Beach survivor criticizes police for inaction during terror attack
- Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- Brazil's ex-president Bolsonaro operated on for hernia
- Vote In favor of Your Favored Sort Of Bevarage
- The Most Vital Crossroads in Olympic History
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
